CAMBRIDGE, Mass., July 31, 2013 /PRNewswire/ -- Metabolix, Inc. (NASDAQ: MBLX), an innovation-driven performance biomaterials company, today reported financial results for the three months ended June 30, 2013.
"We made further progress executing our strategy focused on high-value markets and opportunities," said Richard P. Eno, President and Chief Executive Officer. "In biopolymers, we continue to focus on building the markets for compostable film and bags, performance additives and in key markets requiring functional biodegradation. We are seeing many opportunities where formulations of our PHA materials with other biodegradable polymers can deliver solutions to solve critical customer problems. This quarter, we are pleased to have formalized a collaboration with Samsung Fine Chemicals to focus on expanding the global market for biodegradable polymers. New products we develop through this relationship are expected to benefit the product portfolios of both companies. In addition, we are hearing early positive market feedback on our PVC performance additive products," said Mr. Eno."As a result of this progress, earlier this month we announced the promotion of Johan van Walsem to Chief Operating Officer," Mr. Eno continued. "We are excited to appoint Johan to this new role, which is focused on growing revenue based on our commercial strategy. Johan's experience across nearly every aspect of our portfolio will position him to integrate our unique capabilities for maximum commercial impact."
Mr. Eno continued, "Establishing an ongoing source of PHA supply to integrate with other biodegradable polymers for customer benefit is a key part of our strategy. We continue to develop our supplier relationship with Tianjin GreenBio Materials in China. In Spain, the situation at Antibioticos is becoming clearer and we are actively engaged in an evaluation of op
|SOURCE Metabolix, Inc.|
Copyright©2012 PR Newswire.
All rights reserved